Finoriq insights
TAKEDA PHARMACEUTICAL CO LTD (TAK) Historical Metrics
Review reported fundamentals, derived ratios, grouped financial metrics, and historical charts for TAKEDA PHARMACEUTICAL CO LTD (TAK).
Company Snapshot
- Company
- TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Ticker
- TAK
- Market Cap
- $57B
- Latest Price
- $18.03
- Industry
- Biotech & Pharma
TAKEDA PHARMACEUTICAL CO LTD (TAK) Current Valuation Metrics
Static valuation preview for TAKEDA PHARMACEUTICAL CO LTD (TAK). Market data retrieved 2026-07-08. Filing currency JPY.
| Metric | Value | Source |
|---|---|---|
| P/EMarket cap divided by latest TTM net income. | 3.61x | Net Income | TTM FY 2025 |
| P/SMarket cap divided by latest TTM revenue. | 0.09x | Revenue | TTM FY 2025 |
| P/Operating Cash FlowMarket cap divided by latest TTM operating cash flow. | 0.37x | Operating Cash Flow | TTM FY 2025 |
| Earnings YieldLatest TTM net income divided by market cap. | 27.7% | Net Income | TTM FY 2025 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | 270.9% | Operating Cash Flow | TTM FY 2025 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.